Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Anika to initiate Orthovisc phase III clinical study in U.S. and Canada

April 5, 1999

New oral SLE therapy GL-701 awarded fast track designation

April 5, 1999

Cypress Bioscience closes partnership agreement with Fresenius

April 5, 1999

Celecoxib is an effective antipyretic agent in man

March 26, 1999

Celgene synthesizes potent TNF-alpha and PDE4 inhibitors

March 26, 1999

FDA grants orphan drug status to recombinant Pharming product

March 26, 1999

Inhibitors of MCP-1 disclosed by Zeneca for inflammation

March 25, 1999

Amgen patents novel hydroxamic acid-based MMP inhibitors

March 22, 1999

Pfizer discloses selective hydroxamic acid-based MMP-13 inhibitors

March 19, 1999

FDA approves Prosorba Column for use in rheumatoid arthritis

March 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...